$301.5M biotech IPO puts Hemab on Nasdaq as COAG Friday - Stock Titan
$301.5M biotech IPO puts Hemab on Nasdaq as COAG Friday Stock Titan
ORIGINAL SOURCE →via IPO News (GN)
ADVERTISEMENT
⚡ STAY AHEAD
Events like this, convergence-verified across 689 sources, land in your inbox every Sunday. Free.
GET THE SUNDAY BRIEFING →RELATED · finance
- [FINANCE] [Editorial] Creating a smoke-free generation
- [FINANCE] 1 Mayıs marketler açık mı kapalı mı? 1 Mayıs market çalışma saatleri 2026! BİM, A101, ŞOK, Migros açık mı?
- [FINANCE] Net profit margins for S&P 500 companies are on track to hit a 17-year high this year. Thanks to Trump's corporate tax cuts, 88 of the largest companies in America paid ZERO in federal income last year despite $105 billion in profits.
- [FINANCE] Intel rallies 114% in April on earnings, AI hopes
- [FINANCE] Meta seeks up to $25b in bond sale for AI
- [FINANCE] Clear vision for smarter revenue and stronger institutions in Nigeria